Drug Safety Concerns Shape Manufacturing Policy

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2002, Volume 26, Issue 3

FDA wants manufacturers to revise product labeling and packaging and step up adverse-event monitoring to reduce risky product use.

Related Content:

Regulatory WatchPharmaceutical Technology-03-02-2002
Signing Off from Washington
Industry Challenges Medicare Price Negotiation Scheme
Drug Shortages Continue to Plague FDA and Manufacturers